$ Last:
0.00% Change Percent:
$N/A Open:
$57.25 Previous Close:
$N/A High:
$N/A Low:
0 Volume:
06/12/2019 09:32:17 am Last Trade Date Time:
Quotes are delayed by 15 to 20 minutes.
Stock Date | Open Price | Close Price | High | Low | Volume |
---|---|---|---|---|---|
2019-06-12 | N/A | 57.25 | N/A | N/A | 0 |
2019-06-11 | N/A | 57.25 | N/A | N/A | 0 |
2019-06-10 | 58.10 | 57.25 | 58.88 | 57.11 | 9,399,975 |
2019-06-07 | 56.34 | 58.08 | 58.14 | 56.34 | 6,085,826 |
2019-06-06 | 56.20 | 56.10 | 56.98 | 55.85 | 22,108,643 |
2019-06-05 | 57.35 | 56.51 | 57.50 | 56.39 | 1,635,146 |
2019-06-04 | 57.50 | 57.20 | 58.48 | 56.26 | 9,494,455 |
2019-06-03 | 57.84 | 57.65 | 58.17 | 57.02 | 2,127,805 |
2019-05-31 | 57.63 | 58.35 | 58.44 | 57.53 | 837,625 |
2019-05-30 | 56.50 | 56.35 | 56.72 | 55.93 | 286,156 |
2019-05-29 | 56.90 | 56.54 | 56.90 | 56.23 | 316,980 |
2019-05-28 | 57.40 | 57.10 | 57.42 | 57.05 | 448,986 |
2019-05-27 | 57.26 | 57.40 | 57.5823 | 56.8931 | 163,124 |
2019-05-24 | 57.26 | 57.40 | 57.5823 | 56.8931 | 163,124 |
2019-05-23 | 57.33 | 57.25 | 57.49 | 56.92 | 323,062 |
2019-05-22 | 58.00 | 57.59 | 58.32 | 57.59 | 372,230 |
2019-05-21 | 58.11 | 58.12 | 58.265 | 57.96 | 580,783 |
2019-05-20 | 57.75 | 57.93 | 58.38 | 57.32 | 385,318 |
2019-05-17 | 57.64 | 58.00 | 58.33 | 57.40 | 372,152 |
2019-05-16 | 58.10 | 57.78 | 58.36 | 57.75 | 809,349 |
Bemis Company Inc. Company Name:
BMS Stock Symbol:
NYSE Market:
News, Short Squeeze, Breakout and More Instantly...
Excellent dividend stocks are great to hold in times of economic downturns. Since the best of the best typically don't suspend -- or even reduce -- their dividend payments regardless of market and economic conditions, the regular and predictable dividend payments can help investors smooth o...
Exelixis (NASDAQ: EXEL) and bluebird bio (NASDAQ: BLUE) are two biotech companies that have been moving in opposite directions on the stock market this year. While Exelixis has provided healthy gains -- its stock is up by 52.1% year to date -- Bluebird's shares have slid by 35.2% since t...
bluebird bio (NASDAQ: BLUE) is a biotech company that focuses on gene editing. This technology seeks to treat diseases by replacing the defective genes responsible for them with their healthy counterparts. Year to date, shares of Bluebird are down by 33.9%, which is significantly worse than ...